| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Margaret N Kosek | Q60647167 |
| P2093 | author name string | Maribel Paredes Olortegui | |
| Pablo Peñataro Yori | |||
| P2860 | cites work | A bacterial E3 ubiquitin ligase IpaH9.8 targets NEMO/IKKgamma to dampen the host NF-kappaB-mediated inflammatory response | Q22001534 |
| Shigella flexneri type III secretion system effectors OspB and OspF target the nucleus to downregulate the host inflammatory response via interactions with retinoblastoma protein | Q24315859 | ||
| Antibiotics for the treatment of dysentery in children | Q24613293 | ||
| The versatility of Shigella effectors | Q28259971 | ||
| A look back at an ongoing problem: Shigella dysenteriae type 1 epidemics in refugee settings in Central Africa (1993-1995) | Q33408812 | ||
| Characterisation of early mucosal and neuronal lesions following Shigella flexneri infection in human colon | Q33416439 | ||
| A changing picture of shigellosis in southern Vietnam: shifting species dominance, antimicrobial susceptibility and clinical presentation | Q33518017 | ||
| Preliminary FoodNet data on the incidence of infection with pathogens transmitted commonly through food - 10 states, 2009. | Q33556443 | ||
| Third International Workshop on Reactive Arthritis. 23-26 September 1995, Berlin, Germany. Report and abstracts | Q33579187 | ||
| Emergence of a new multidrug-resistant serotype X variant in an epidemic clone of Shigella flexneri | Q33627338 | ||
| Innate immune detection of the type III secretion apparatus through the NLRC4 inflammasome | Q33733606 | ||
| Characterization of WRSs2 and WRSs3, new second-generation virG(icsA)-based Shigella sonnei vaccine candidates with the potential for reduced reactogenicity | Q34394744 | ||
| Molecular characterization of multidrug-resistant Shigella species isolated from epidemic and endemic cases of shigellosis in India | Q34593361 | ||
| Life on the inside: the intracellular lifestyle of cytosolic bacteria | Q34975988 | ||
| Macrolide-resistant Shigella sonnei | Q37009590 | ||
| Structure and genetics of Shigella O antigens | Q37142131 | ||
| Synthesis, characterization, and immunogenicity in mice of Shigella sonnei O-specific oligosaccharide-core-protein conjugates | Q37194696 | ||
| Vaccination against shigellosis: is it the path that is difficult or is it the difficult that is the path? | Q37232206 | ||
| Shigella type III secretion effectors: how, where, when, for what purposes? | Q37373930 | ||
| Reactive arthritis: clinical aspects and medical management | Q37500771 | ||
| Shigella infection of intestinal epithelium and circumvention of the host innate defense system | Q37610850 | ||
| Clinical practice. Bacterial diarrhea | Q37614722 | ||
| Inactivated and subunit vaccines to prevent shigellosis | Q37640115 | ||
| Reactive arthritis after enteric infections in the United States: the problem of definition | Q37660389 | ||
| Epidemiologic aspects of shigellosis and other causes of dysentery in Thailand | Q37754322 | ||
| Prolonged remission of chronic reactive arthritis treated with three infusions of infliximab | Q37853501 | ||
| Characteristics of children with Shigella encephalopathy: experience from a large urban diarrhea treatment center in Bangladesh | Q39912195 | ||
| Immunogenicity and efficacy of highly purified invasin complex vaccine from Shigella flexneri 2a. | Q40123700 | ||
| Emergence of resistance to third-generation cephalosporin in Shigella--a case report | Q43231792 | ||
| Magnitude of drug resistant Shigellosis: a report from Bangalore | Q43279809 | ||
| Beneficial role of green plantain [Musa paradisiaca] in the management of persistent diarrhea: a prospective randomized trial | Q43310553 | ||
| A synthetic carbohydrate-protein conjugate vaccine candidate against Shigella flexneri 2a infection | Q43461979 | ||
| Epidemiology of highly endemic multiply antibiotic-resistant shigellosis in children in the Peruvian Amazon. | Q45138749 | ||
| Bacteria hijack integrin-linked kinase to stabilize focal adhesions and block cell detachment. | Q45986472 | ||
| Green banana reduces clinical severity of childhood shigellosis: a double-blind, randomized, controlled clinical trial | Q46076041 | ||
| A soluble form of the pilus protein FimA targets the VDAC-hexokinase complex at mitochondria to suppress host cell apoptosis | Q46219028 | ||
| Tracking the dynamic interplay between bacterial and host factors during pathogen-induced vacuole rupture in real time | Q48827027 | ||
| Disease burden of post-infectious irritable bowel syndrome in The Netherlands | Q48864958 | ||
| Post-infectious functional gastrointestinal disorders in children | Q50061795 | ||
| Longitudinal studies of infectious diseases and physical growth of children in rural Bangladesh. II. Incidence of diarrhea and association with known pathogens | Q50584438 | ||
| Vaccination of children in low-resource countries against Shigella is unlikely to present an undue risk of reactive arthritis. | Q55052109 | ||
| Quinolone resistance among Shigella spp. isolated from travellers returning from India | Q56778898 | ||
| Rapid emergence of third generation cephalosporin resistant Shigella spp. in Southern Vietnam | Q56875735 | ||
| Age-related efficacy of Shigella O-specific polysaccharide conjugates in 1-4-year-old Israeli children. | Q64948328 | ||
| Neutrophil antimicrobial proteins enhance Shigella flexneri adhesion and invasion | Q83888582 | ||
| Purification and characterization of an immunogenic outer membrane protein of Shigella flexneri 2a | Q84363216 | ||
| P433 | issue | 5 | |
| P921 | main subject | shigellosis | Q327298 |
| antibiotic resistance | Q380775 | ||
| P304 | page(s) | 475-480 | |
| P577 | publication date | 2010-10-01 | |
| P1433 | published in | Current Opinion in Infectious Diseases | Q15724406 |
| P1476 | title | Shigellosis update: advancing antibiotic resistance, investment empowered vaccine development, and green bananas | |
| P478 | volume | 23 |
| Q38660838 | Antimicrobial therapy of acute diarrhoea: a clinical review |
| Q30252712 | Association between enteropathogens and malnutrition in children aged 6-23 mo in Bangladesh: a case-control study |
| Q35805439 | Broadly protective Shigella vaccine based on type III secretion apparatus proteins |
| Q47795634 | Considerations for using ETEC and Shigella disease burden estimates to guide vaccine development strategy. |
| Q38972785 | Conventional and molecular investigation of Shigella isolates in relation to an outbreak in the area of Isfahan, Iran |
| Q38586531 | Convergent synthesis of the tetrasaccharide repeating unit of the O-antigen of Shigella boydii type 9. |
| Q34177006 | Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study. |
| Q45022652 | Drug therapy of infectious diarrhea: part 1: acute diarrhea |
| Q37066116 | Establishment of a Shigella sonnei human challenge model in Thailand |
| Q41611746 | Expression of different bacterial cytotoxins is controlled by two global transcription factors, CRP and Fis, that co-operate in a shared-recruitment mechanism |
| Q36866917 | Genetic characterization of antimicrobial resistance of Shigella flexneri 1c isolates from patients in Egypt and Pakistan |
| Q54088652 | Identification of etiology-specific diarrhea associated with linear growth faltering in Bangladeshi infants. |
| Q35071188 | Laboratory-based prospective surveillance for community outbreaks of Shigella spp. in Argentina |
| Q30422560 | Molecular diagnosis of diarrhea: current status and future potential |
| Q30456827 | New concepts in diagnostics for infectious diarrhea |
| Q36379497 | Preventing acute gut wall damage in infectious diarrhoeas with glycosylated dendrimers |
| Q38057688 | PulseNet China, a model for future laboratory-based bacterial infectious disease surveillance in China |
| Q42324204 | Steps for Shigella Gatekeeper Protein MxiC Function in Hierarchical Type III Secretion Regulation. |
| Q40458257 | Tyrosine kinases, drugs, and Shigella flexneri dissemination. |
| Q35887055 | Vaccines for viral and bacterial pathogens causing acute gastroenteritis: Part II: Vaccines for Shigella, Salmonella, enterotoxigenic E. coli (ETEC) enterohemorragic E. coli (EHEC) and Campylobacter jejuni. |
Search more.